Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statins

Curr Rheumatol Rep. 2007 Apr;9(1):1-3. doi: 10.1007/s11926-007-0014-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Endothelial Cells / drug effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Neovascularization, Physiologic / drug effects*
  • Pilot Projects
  • Raynaud Disease / drug therapy
  • Scleroderma, Systemic / drug therapy*
  • Stem Cells / drug effects

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors